# EDGAR Filing Document

**Accession Number:** 0001357325
**File Stem:** 0001127602-25-020229
**Filing Date:** 2025-8
**Character Count:** 10897
**Document Hash:** e376be60614a02ebdc406053462b45cc
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001127602-25-020229.hdr.sgml**: 20250807

**ACCESSION NUMBER**: 0001127602-25-020229

**CONFORMED SUBMISSION TYPE**: 4

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20250805

**FILED AS OF DATE**: 20250807

**DATE AS OF CHANGE**: 20250807

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Seeger Laureen
- **CENTRAL INDEX KEY:** 0001357325

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-07657
- **FILM NUMBER:** 251194008

**MAIL ADDRESS:**
- **STREET 1:** C/O AMERICAN EXPRESS COMPANY
- **STREET 2:** 200 VESEY STREET
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10285
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** AMERICAN EXPRESS CO
- **CENTRAL INDEX KEY:** 0000004962
- **STANDARD INDUSTRIAL CLASSIFICATION:** FINANCE SERVICES [6199]
- **ORGANIZATION NAME:** 02 Finance
- **EIN:** 134922250
- **STATE OF INCORPORATION:** NY
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 200 VESEY STREET
- **STREET 2:** 50TH FLOOR
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10285
- **BUSINESS PHONE:** 2126402000

**MAIL ADDRESS:**
- **STREET 1:** 200 VESEY STREET
- **STREET 2:** 50TH FLOOR
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10285

## Ex-24

```

POWER OF ATTORNEY

Know by all these presents that the undersigned hereby constitutes and
appoints each of David A. Kanarek, James J. Killerlane III and Brandon
N. Egren, signing singly, the undersigned's true and lawful
attorney-in-fact to:

(1) prepare, execute for and on behalf of the undersigned, in the
undersigned's name, place and stead in any and all capacities related to
securities of the American Express Company (the "Company"), any and all
filings by the undersigned with the United States Securities and
Exchange Commission (the "SEC") (a) pursuant to Section 16 of the
Securities Exchange Act of 1934 and the rules thereunder, as amended
(the "1934 Act"), and (b) pursuant to Rule 144 under the Securities Act
of 1933 and the rules thereunder, as amended (the "1933 Act"), and with
respect to either of the foregoing clauses (a) and (b), any other forms or
reports the undersigned may be required to file in connection with the
undersigned's ownership, acquisition, or disposition of securities of the
Company;

(2) do and perform any and all acts for and on behalf of the undersigned
which may be necessary or desirable to complete, execute and deliver any
such filing as described in paragraph (1) above, or other form or report,
and timely file such form or report with the SEC and any stock exchange
or similar authority; and

(3) take any other action of any type whatsoever in connection with paragraphs
(1) and (2) above which, in the opinion of such attorney-in-fact, may be of
benefit to, in the best interest of, or legally required by, the
undersigned, it being understood that the documents executed by such
attorney-in-fact on behalf of the undersigned pursuant to this Power of
Attorney shall be in such form and shall contain such terms and
conditions as such attorney-in-fact may approve in such
attorney-in-fact's discretion.

The undersigned hereby grants to each such attorney-in-fact full power
and authority to do and perform any and every action whatsoever
requisite, necessary or proper to be done in the exercise of any of the
rights and powers herein granted, as fully to all intents and purposes as
the undersigned might or could do if personally present, with full power
of substitution or revocation, hereby ratifying and confirming all that
such attorney-in-fact, or such attorney-in-fact's substitute or
substitutes, shall lawfully do or cause to be done by virtue of this
power of attorney and the rights and powers herein granted.
The undersigned acknowledges that the foregoing attorneys-in-fact, in
serving in such capacity at the request of the undersigned, are not
assuming, nor is the Company assuming, any of the undersigned's
responsibilities to comply with Section 16 of the 1934 Act or Rule 144
under the 1933 Act.

This Power of Attorney shall supersede and replace all prior powers of
attorney granted by the undersigned with respect to any filings by the
undersigned with the SEC pertaining to securities of the Company and shall
remain in full force and effect until the undersigned is no longer required
to file any such filing as described in paragraph (1) above, unless earlier
revoked by the undersigned in a signed writing delivered to the
foregoing attorneys-in-fact.

IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to
be executed as of July 23, 2025.

By: /s/ Laureen E. Seeger
Laureen E. Seeger

```

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 4

### STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

[ ] Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Seeger Laureen<br><sub>(Last) (First) (Middle)</sub><br>200 VESEY STREET, AMERICAN EXPRESS TOWER<br><sub>(Street)</sub><br>NEW YORK, NY 10285-5001<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2025-08-05 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director [ ] 10% Owner<br>[X] Officer (give title below) [ ] Other (specify below)<br>_Chief Legal Officer_ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>AMERICAN EXPRESS CO [ AXP ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | 3. Transaction Code (V) | 3. Transaction Code (V) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | Code | V | Amount | (A) or (D) | Price | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| Common Stock | 2025-08-05 |  | S |  | 39383 | D | 297.24<sup>(1)</sup> | 31338.908<sup>(2)</sup> | D |  |
| Common Stock | 2025-08-05 |  | S |  | 22338 | D | 297.88<sup>(3)</sup> | 9000.908 | D |  |
| Common Stock | 2025-08-06 |  | M |  | 16998 | A | $177.06 | 25998.908 | D |  |
| Common Stock | 2025-08-06 |  | S |  | 16998 | D | 294.83<sup>(4)</sup> | 9000.908 | D |  |

---

## Table II - Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | 4. Transaction Code (V) | 4. Transaction Code (V) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 6. Date Exercisable and Expiration Date | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Underlying Securities | 7. Title and Amount of Underlying Securities | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| Employee Stock Option (Right to Buy) | $177.06 | 2025-08-06 |  | M |  |  | 16998 | 2025-01-28 | 2032-01-28 | Common Stock | 16998 | $0 | 0 | D |  |

---

### Footnotes:

(1) The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were sold in multiple transactions at prices ranging from $297.02 to $297.61. The reporting person undertakes to provide to American Express Company, any security holder of American Express Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range.

(2) Includes shares acquired pursuant to dividend reinvestment.

(3) The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were sold in multiple transactions at prices ranging from $297.62 to $298.48. The reporting person undertakes to provide to American Express Company, any security holder of American Express Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range.

(4) The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were sold in multiple transactions at prices ranging from $294.53 to $295.24. The reporting person undertakes to provide to American Express Company, any security holder of American Express Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range.

**Remarks:**
Exhibit 24: Power of Attorney

**Signature:** /s/ James J. Killerlane III, attorney in-fact  
**Date:** 2025-08-07

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**